Pneumococcal capsular polysaccharide serotype 19F (CPS 19F)

Pneumococcal capsular polysaccharide serotype 19F is a complex carbohydrate polymer that encapsulates the bacterium Streptococcus pneumoniae serotype 19F [1, 11]. It serves as a primary virulence factor by providing a physical barrier that inhibits opsonophagocytosis and limits the deposition of complement components like C3 on the bacterial surface [3, 8]. This immune evasion mechanism allows the pathogen to survive in the host bloodstream and tissues, leading to serious infections such as pneumonia, meningitis, and bacteremia [1, 10]. Serotype 19F is also a frequent cause of acute otitis media in pediatric populations [8, 14]. Because of its clinical significance, this polysaccharide is used as a target antigen in various pneumococcal vaccines, including conjugate (e.g., PCV13, PCV20) and polysaccharide-only (PPSV23) formulations [9, 17]. In conjugate vaccines, the 19F polysaccharide is covalently linked to a carrier protein to enhance immunogenicity and induce long-term T-cell-dependent memory [1, 13]. Clinical monitoring of vaccine efficacy often involves measuring serotype-specific IgG levels and opsonophagocytic activity [8, 11].

Other names

PnPS 19FStreptococcus pneumoniae serotype 19F capsular polysaccharidePneumococcal polysaccharide type 19F19F capsular polysaccharide

Induction of active immunity by stimulating the production of serotype-specific opsonophagocytic antibodies that facilitate bacterial clearance by the host immune system [1, 10].